Riskpilot← Back to searchSign inGet full accessAllergon Aktiebolag
ABActiveOrg 5560899899Välingevägen 309Growing of spices, aromatic, drug and pharmaceutical crops · NACE 0128Est. 196344 employees
Revenue 2024
SEK 143,9M
+3% vs 2023
EBITDA margin
20.4%
-49% vs 2023
Equity ratio
62.5%
Financial strength
Net profit 2024
SEK 18,4M
+35% vs 2023
| Revenue | SEK 143,9M | +3% |
| EBITDA | SEK 29,4M | -49% |
| Net profit | SEK 18,4M | +35% |
| Total assets | SEK 707M | +8% |
| Equity | SEK 441,5M | +22% |
| Employees | 44 | — |
Legal name
Allergon Aktiebolag
Org number
5560899899
Legal form
Aktiebolag
NACE code
0128 · Growing of spices, aromatic, drug and pharmaceutical crops
Founded
15 november 1963
Share capital
SEK 100 000
Employees
44 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Martinsson, Jan Anders
Company purpose
Bolaget har till föremål för sin verksamhet att utveckla, till- verka och marknadsföra råvaror för allergenprodukter och näringspollen samt bedriva därmed förenlig verksamhet.
Address
Välingevägen 309
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 130 282 | 130 556 | 137 684 | 139 762 | 143 887 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 27 760 | 15 696 | −18 772 | 58 033 | 29 382 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 27 760 | 15 696 | −18 772 | 58 033 | 29 382 |
| Net financials | 2 251 | 4 003 | 29 964 | 15 918 | 18 693 |
| Profit before tax | 3 965 | 3 498 | 27 104 | 13 583 | 18 385 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 3 965 | 3 498 | 27 104 | 13 583 | 18 385 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 549 533 | 570 589 | 592 118 | 656 947 | 707 016 |
| Equity | 291 836 | 320 551 | 362 861 | 362 321 | 441 536 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 234 217 | 225 562 | 206 571 | 272 400 | 244 016 |
| Total debt | 234 217 | 225 562 | 206 571 | 272 400 | 244 016 |
EBITDA margin
20.4%
This company
15.8%
Market median
+29% vs market
20202024
Equity ratio
62.5%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
4.2%
This company
18.4%
Market median
-77% vs market
20202024
Net profit margin
12.8%
This company
8.1%
Market median
+58% vs market
20202024
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TM Chief Auditor | Chief Auditor | 2024 |
JA Chief Executive Officer | Chief Executive Officer | 2026 |
LV Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (2) | ||
LA Chief Auditor | Chief Auditor | 2020 – 2024 |
PH Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CB Diagnostics Holding AB
Allergon Aktiebolag Board members of Allergon Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Anders Per Nilsson | Chief Auditor | 0 companies |
| Torbjörn Mikael Åberg | Chief Auditor | 0 companies |
| Jan Anders Martinsson | Chief Executive Officer | 0 companies |
| Poul Hansen Brunsgaard | Chief Executive Officer | 0 companies |
| Lasse Veng | Chief Executive Officer | 0 companies |
| Lynn Gray | Board of Directors | 0 companies |
| Anders Göran Trygg | Board of Directors | 0 companies |
| Kristin Malin Christiansson | Board of Directors | 0 companies |
| Sara Maria Carrella | Board of Directors | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |